LBF20406LT10: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity=14,15-dehydro LTB4 is reported as a selective ligand for the BLT1 and act as a selective antagonist of LTB4 in vivo.[[Reference:Wang_S:Gustafson_E:Pang_L:Qiao_X:Behan_J:Maguire_M:Bayne_M:Laz_T:,J. Biol. Chem.,2000,275,40686|{{RelationTable/GetFirstAuthor|Reference:Wang_S:Gustafson_E:Pang_L:Qiao_X:Behan_J:Maguire_M:Bayne_M:Laz_T:,J. Biol. Chem.,2000,275,40686}}]] | |||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 06:00, 7 January 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR3119 |
| LipidMaps | LMFA03020017 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20406LT10 |
| 14,15-dehydro Leukotriene B4 | |
|---|---|
| |
| Structural Information | |
| 5S,12R-dihydroxy-6Z,8E,10E-eicosatriene-14-ynoic acid | |
| |
| Formula | C20H30O4 |
| Exact Mass | 334.21440944799997 |
| Average Mass | 334.4498 |
| SMILES | C(CC#CC[C@H](C=CC=CC=C[C@H](CCCC(O)=O)O)O)CCC |
| Physicochemical Information | |
| 14,15-dehydro LTB4 is reported as a selective ligand for the BLT1 and act as a selective antagonist of LTB4 in vivo. Wang_S et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
